Immunosuppressive Agents: all 5,940 studies that test it
Page 51 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine InhibitorsCompletedNCT00456235Phase 4
- Thalidomide at Low Dose for the Treatment of Patient With Myelodysplastic Syndromes - THAL-SMD-200CompletedNCT00455910Phase 2
- CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's LymphomaTerminatedNCT00455897Phase 2
- a Phase II Study in Primary Central Nervous System LymphomaStatus unknownNCT00455286Phase 2
- Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple MyelomaCompletedNCT00452569Phase 3
- Objective Study in Rheumatoid ArthritisCompletedNCT00451971Phase 4
- Sirolimus in Treating Patients With HIV-Related Kaposi's SarcomaCompletedNCT00450320Phase 1
- Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate CancerTerminatedNCT00450008Phase 2
- Drug Interaction Study of Sorafenib and Rapamycin in Advanced MalignanciesCompletedNCT00449280Phase 1
- Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney CancerCompletedNCT00448149Phase 1/2
- Combination Therapy for Neovascular Age Related Macular DegenerationWithdrawnNCT00447031Not applicable
- Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid ArthritisCompletedNCT00446784Phase 1
- Safety Study of RAD001 to Treat Patients With Metastatic Kidney CancerCompletedNCT00446368Phase 2
- Autologous Stem Cell Transplants for Chronic Myelogenous LeukemiaWithdrawnNCT00446173Phase 2
- Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid MetaplasiaCompletedNCT00445900Phase 2
- An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing SpondylitisCompletedNCT00444340Phase 4
- Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid ArthritisCompletedNCT00443950Phase 3
- Pharmacokinetics of Everolimus and Enteric-Coated Mycophenolatesodium Before and After Withdrawal of Cyclosporine in Renal Transplant PatientsCompletedNCT00443937Phase 4
- Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic RetinopathyCompletedNCT00443521Phase 2/3
- GEM05 for Patients With Multiple Myeloma More Than 65 Years OldCompletedNCT00443235Phase 3
- Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot StudyStatus unknownNCT00443105Phase 2
- Treatment With High Dose Methotrexate in Patients With Eosinophilic FasciitisCompletedNCT00441961Not applicable
- Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV MelanomaCompletedNCT00438984Phase 1
- Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple MyelomaStatus unknownNCT00438841Phase 2
- Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast CancerStatus unknownNCT00436709Not applicable
- Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 DiabetesCompletedNCT00434850Phase 2
- Islet Transplantation in Type 1 DiabetesCompletedNCT00434811Phase 3
- Safety of Everolimus and Pemetrexed in Lung Cancer PatientsCompletedNCT00434174Phase 1
- Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing SpondylitisCompletedNCT00434044Phase 3
- CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast CancerWithdrawnNCT00434031Phase 2
- Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy ParticipantsCompletedNCT00433485Phase 1
- Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic ArthritisCompletedNCT00432406Phase 4
- Basiliximab in Moderate to Severe Ulcerative ColitisCompletedNCT00430898Phase 2
- Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated VasculitidesCompletedNCT00430105Phase 2/3
- Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative StudyCompletedNCT00429377Phase 3
- Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's LymphomaCompletedNCT00428142Phase 2
- Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant RecipientsCompletedNCT00428064Phase 3
- Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast CancerCompletedNCT00426530Phase 1
- Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004CompletedNCT00426101Phase 3
- Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent ImplantationStatus unknownNCT00426049Phase 3
- Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By SurgeryCompletedNCT00424203Phase 2
- Cisplatin and Everolimus in Treating Patients With Advanced Solid TumorsCompletedNCT00423865Phase 1
- A Study of RAD001 and Sunitinib in Metastatic Renal Cell CarcinomaCompletedNCT00422344Phase 1
- An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing SpondylitisCompletedNCT00421980Phase 3
- Study Evaluating Etanercept Treatment of Patients With Ankylosing SpondylitisCompletedNCT00421915Phase 3
- Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative CancerCompletedNCT00420563Phase 2
- Shift to Everolimus (RAD) Kidney Sparing StudyTerminatedNCT00420537Phase 4
- Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing SpondylitisCompletedNCT00418548Phase 3
- Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic SclerosisTerminatedNCT00418132Phase 1
- Effects of FTY720 on Heart and Lung Functions in Healthy VolunteersCompletedNCT00416845Phase 1
- Etanercept SFP in RA PatientsCompletedNCT00413452Phase 3
- Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic RetinopathyCompletedNCT00411333Early Phase 1
- Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum CancerCompletedNCT00409994Phase 1/2
- Thymoglobulin (ATG) Dose Finding StudyTerminatedNCT00409695Phase 1/2
- Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty PatientsCompletedNCT00409656Phase 2
- Study of TNF-Antagonism in Metabolic SyndromeCompletedNCT00409318Not applicable
- Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis PatientsCompletedNCT00408187Phase 3
- Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular EdemaStatus unknownNCT00407849Phase 1/2
- Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With RestasisCompletedNCT00407043Phase 4
- Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma PatientsCompletedNCT00406978Phase 1/2
- Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?CompletedNCT00405431Not applicable
- A Study of Everolimus in Combination With Imatinib in Metastatic MelanomaTerminatedNCT00402662Phase 2
- Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)CompletedNCT00402558Phase 1
- Immunosuppressive Therapy With Certican (Everolimus) After Lung TransplantationCompletedNCT00402532Phase 3
- Study of Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors Non-Curable With Standard TherapyTerminatedNCT00402415Phase 1
- Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic RetinopathyCompletedNCT00401115Phase 1
- Combination Chemotherapy in Treating Young Male Patients With Hodgkin's LymphomaCompletedNCT00398554Phase 2
- Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By SurgeryStatus unknownNCT00398489Phase 2
- Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's LymphomaStatus unknownNCT00397800Phase 1/2
- A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging StudyCompletedNCT00396747Phase 4
- Sirolimus Therapy for Poor Prognosis Immunoglobulin A NephropathyCompletedNCT00396721Phase 2
- Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular CarcinomaCompletedNCT00396682Phase 3
- Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.CompletedNCT00393471Phase 3
- Clobetasol Versus Pimecrolimus for Vulvar Lichen SclerosusCompletedNCT00393263Phase 2
- Thalidomide for the Treatment of Malnutrition Inflammation Syndrome in Peritoneal Dialysis PatientsWithdrawnNCT00390247Phase 4
- Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT00390195Phase 1/2
- Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid TumorsCompletedNCT00390156Phase 1
- Study of LJP 394 (Abetimus Sodium) in Lupus PatientsWithdrawnNCT00390091Phase 2
- Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal BleedingCompletedNCT00389935Phase 2
- Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to FluorouracilCompletedNCT00389870Phase 3
- Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's LymphomaWithdrawnNCT00389506Not applicable
- Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma MultiformeCompletedNCT00387400Phase 1
- Sorafenib and RAD001 Renal Cell CarcinomaCompletedNCT00384969Phase 1
- A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver RecipientsCompletedNCT00384202Phase 3
- A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney RecipientsCompletedNCT00384137Phase 3
- Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to PterygiaCompletedNCT00383396Phase 4
- A Study of ZYC300 Administered With Cyclophosphamide Pre-DosingCompletedNCT00381173Phase 1
- Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast CancerCompletedNCT00379015Phase 2
- Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple MyelomaCompletedNCT00378768Phase 2
- The Effectiveness of Lower Cyclosporine Doses for PsoriasisWithdrawnNCT00377325Phase 2
- Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesTerminatedNCT00376519Phase 1
- Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell TransplantCompletedNCT00376480Phase 1
- Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver TransplantationTerminatedNCT00375895Phase 3
- Rapamycin With Grapefruit Juice for Advanced MalignanciesCompletedNCT00375245Phase 1
- Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal AllograftsCompletedNCT00374647Phase 4
- Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host DiseaseTerminatedNCT00373815Phase 1
- Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma PatientsCompletedNCT00373646Phase 2
- Triamcinolone Acetonide in Silicone-Filled Eyes as Adjunctive Treatment for Proliferative VitreoretinopathyCompletedNCT00373282Phase 3
- Sequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular EdemaCompletedNCT00371410Phase 1
- Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus NephritisCompletedNCT00371319Phase 4